As of Wednesday, the universe of cannabis-focused exchange-traded funds (ETFs) has grown by one. The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS) began trading on September 2 at a per-share price of $25.00 and 100,000 shares outstanding.
As the West Coast matures from the early Green Rush and Midwest markets like Michigan and Illinois hit their stride with recent legalization, all eyes are on the Northeast as the sleeping giant that will radically change the national cannabis landscape for 2021 and beyond.
Although the Canadian cannabis retail sector has not lived up to the expectations that were associated with the 2.0 market, the industry has recorded major advancements so far this year. From the number of open retail outlets to the types of products that are being offered to consumers, the landscape of the Canadian cannabis retail market has been slowly changing for the better.
Investors and innovators are always looking for the best areas of growth in the public sector. Currently, investing in the cannabis industry has proved to be one of the most beneficial returns. With the current cannabis movement across the world, the emerging U.S. market has made investors even more eager to invest in this space.
When Congress passed the 2018 Farm Bill and the U.S. president signed it in December of that year, hemp was removed from the list of Schedule I drugs that includes heroin, cocaine and marijuana. Products derived from industrial hemp containing less than 0.3% by weight of delta-9 tetrahydrocannabinol (THC) became legal and led to what became known as Cannabis 2.0, the sale of non-psychoactive products derived from industrial hemp.
Hemp — and the CBD products that can be made from it — may have been legalized by the 2018 federal farm bill, but members of the nascent industry say new federal rules make it almost impossible to make hemp products without breaking the law.
An alphabet soup of federal and state agencies oversees the growth, processing and distribution of hemp and its byproducts.
Recently, the excellent website, MarijuanaMoment.com, carried two articles by Kyle Jaeger, their Los Angeles-based associate editor, "Trump Voices Concern That Putting Marijuana On The Ballot Makes Republicans Lose" and "Biden's Marijuana Decriminalization Plan Is 'Meaningless', says Democratic Congressman"; that really makes me wonder i
In early 2020, the world as we know it changed when COVID-19 erupted into a global health crisis. This virus continues to wreak havoc on public safety and the economy, sparing no community or industry. Despite these challenges, the cannabis industry has shown incredible resilience through these uncertain times.
In 2018, sales of medical and recreational cannabis in the United States were nearly nine times higher than sales of Oreo cookies, according to a report from New Dawn Risk entitled, ‘Understanding and opening up the US cannabis insurance market’. Despite the significant demand – the US market saw an estimated $8 billion in legalized cannabis sales in 2018 – there are a few big problems blocking the way to further progress in the US cannabis industry.
Canada and the U.S. currently generate a majority of the cannabis industry’s revenue. While both countries are significant factors as the market matures, other nations will take up a share as well.
For example, Mexico, New Zealand and several other countries are considering adult use legalization, and could assume their place in the global market.
Several cannabis industry experts told Benzinga that several regions and nations are already ones to keep an eye on when tracking the global marijuana growth.
